沉默PCCA通过调节EMT和M1巨细胞极化抑制CRC生长和扩散
Chuyi Zhang1,2,3, Zhinan Zheng1,2, Huaiming Wang2,4
1Department of Anaesthesia, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
International journal of medical sciences
|January 2, 2025
概括
propionyl-CoA 碳素酶α链 (PCCA) 促进结直肠癌 (CRC) 的进展和转移. 抑制PCCA可以减少CRC细胞的入侵,生长和扩散,这表明PCCA是CRC治疗的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症转移研究 癌症转移研究
背景情况:
- 结肠直肠癌 (CRC) 的进展和转移由于治疗目标有限,造成了重大临床挑战.
- 初步发现表明,propionyl-CoA carboxylase alpha chain (PCCA) 基因在CRC中被上调,需要对其功能作用进行研究.
研究的目的:
- 为了研究尼尔-CoA碳素酶α链 (PCCA) 在结直肠癌 (CRC) 进展和转移中的功能性作用.
- 确定PCCA是否可以作为CRC的潜在治疗点.
主要方法:
- 利用生物信息学分析,人类结直肠瘤组织和CRC细胞系来评估PCCA表达.
- 采用伤口愈合,Transwell,CCK-8试验,西式抹杀,小鼠模型,流细胞计和定量PCR来评估PCCA对CRC细胞行为的影响,瘤生长,转移和巨细胞两极分化.
主要成果:
- 在CRC组织中PCCA的高表达与预后不佳相关. 通过PCCA的淘汰,显著减少了CRC细胞的迁移,入侵和增殖.
- 抑制PCCA导致表皮细胞-介质细胞过渡 (EMT) 逆转,ERK/GSK3β通路的失活,并抑制瘤生长和肺转移.
- 击败PCCA促进了瘤微环境中的M1-巨细胞两极分化.
结论:
- 通过逆转EMT,不激活ERK/GSK3β通路,并促进M1-巨细胞两极分化,PCCA Knockdown有效地抑制结直肠癌的进展和转移.
- 现在,PCCA成为控制结直肠癌进展和转移的有希望的治疗标.
更多相关视频
10:28Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
6.4K
10:59Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
Published on: November 23, 2017
12.3K
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
